Stockscreener 앱 받기
1.38
0.00%
0.00
전일 마감가:
$1.38
열려 있는:
$1.39
하루 거래량:
285.42K
Relative Volume:
0.50
시가총액:
$105.34M
수익:
$3.64M
순이익/손실:
$-132.20M
주가수익비율:
-0.463
EPS:
-2.9806
순현금흐름:
$-51.17M
1주 성능:
+5.34%
1개월 성능:
-7.38%
6개월 성능:
+9.52%
1년 성능:
-50.18%
1일 변동 폭
$1.3401
$1.47
1주일 범위
$1.21
$1.47
52주 변동 폭
$1.09
$4.1907
Cibus Inc Stock (CBUS) Company Profile
명칭
Cibus Inc
전화
(858) 450-0008
주소
6455 NANCY RIDGE DRIVE, SAN DIEGO
Compare CBUS vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
1.38 | 105.34M | 3.64M | -132.20M | -51.17M | -2.9806 |
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.03B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
638.88 | 67.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
806.46 | 50.76B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
297.45 | 40.12B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
151.56 | 32.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-29 | 개시 | Alliance Global Partners | Buy |
| 2024-07-19 | 재개 | Canaccord Genuity | Buy |
| 2023-10-09 | 개시 | H.C. Wainwright | Buy |
| 2023-07-19 | 재개 | Canaccord Genuity | Buy |
Cibus Inc 주식(CBUS)의 최신 뉴스
Cibus Q1 earnings call highlights - MSN
Cibus (CBUS) registers 10.74M shares issuable on warrants — issuer to receive proceeds - Stock Titan
Cibus (NASDAQ: CBUS) files at‑the‑market $50M shelf with Jefferies - Stock Titan
CBUS SEC FilingsCIBUS INC 10-K, 10-Q, 8-K Forms - Stock Titan
Cibus, Inc. (NASDAQ:CBUS) Q1 2026 Earnings Call Transcript - Insider Monkey
Cibus Earnings Call: Cash Extended, Execution Critical - TipRanks
CBUS Technical Analysis | Trend, Signals & Chart Patterns | CIBUS INC (NASDAQ:CBUS) - ChartMill
MSN Money - MSN
Number of shareholders of Cibus, Inc. – NASDAQ:CBUS - TradingView
Cibus (CBUS) Q1 2026 Earnings: EPS -$0.33, Revenue $1.681M -- Bo - GuruFocus
Cibus Inc to offer securities with aggregate initial offering price up to $200 millionSEC filing - marketscreener.com
Cibus IncTo Offer Securities With Aggregate Initial Offering Price Up To $200 MillionSEC Filing - TradingView
Cibus (CBUS) registers $200M shelf and $50M ATM via Jefferies - Stock Titan
Q1 2026 Cibus Inc Earnings Call Transcript - GuruFocus
Cibus, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Cibus Inc (CBUS) Q1 2026 Earnings Call Highlights: Strategic Adv - GuruFocus
Cibus, Inc.Class A Common Stock (NQ: CBUS - FinancialContent
Cibus, Inc. (CBUS) Q1 2026 Earnings Call Transcript Summary - Moomoo
Cibus outlines runway into late Q1 2027 while shifting US rice launch to 2029 - MSN
Cibus (CBUS) reports Q1 loss, beats revenue estimates - MSN
Earnings call transcript: Cibus Q1 2026 reveals improved cost efficiency - Investing.com UK
Cibus Q1 Earnings Call Highlights - MarketBeat
Earnings call transcript: Cibus Q1 2026 reveals improved cost efficiency By Investing.com - Investing.com Nigeria
Cibus (CBUS) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
CBUS: Commercial momentum, cost discipline, and regulatory wins drive progress toward 2027 launches - TradingView
Cibus Q1 2026 Earnings Call: Complete Transcript - Benzinga
Cibus (NASDAQ:CBUS) Edges Past Q1 Estimates as Cost Cutting Narrows Loss, Stock Jumps After-Hours - ChartMill
Cibus Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Cibus (CBUS) trims Q1 2026 loss but warns on going concern risk - Stock Titan
Cibus: Q1 Earnings Snapshot - marketscreener.com
Cibus (CBUS) Q1 2026 Earnings Transcript - The Globe and Mail
Cibus (CBUS) narrows Q1 2026 loss as cash rises to $30.3M - Stock Titan
Press Release: Cibus Reports First Quarter Financial Results and Provides Business Update - Moomoo
CBUS: Commercial execution advances with cost discipline and capital raise, supporting 2027 LATAM rice launch - TradingView
Cibus Inc expected to post a loss of 33 cents a shareEarnings Preview - TradingView
Cibus (CBUS) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
FMR LLC Stakes 15.0% in Cibus Inc. (NYSE: CBUS) via Schedule 13G/A - Stock Titan
Cibus Transfers Gene-Edited Herbicide-Tolerance Traits in Rice to Interoc Ahead of Latin American Launch - iGrow News
Cibus transfers gene-edited rice materials to partner Interoc By Investing.com - Investing.com Australia
Cibus (CBUS) Advances Herbicide Tolerance Testing with Interoc - GuruFocus
Cibus transfers gene-edited rice materials to partner Interoc - Investing.com
Cibus Inc (CBUS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.98%
1.33%
자본화:
|
볼륨(24시간):